Combining the strengths of Phillips Medisize and Vectura enhances our ability to deliver a broader portfolio of innovative inhalation solutions to our pharmaceutical partners and to fulfill our shared vision of helping patients live healthier lives.
Together, we can offer a wider range of formulation, device design and combination product development, as well as manufacturing services to support the growing global need for inhalation therapies to treat chronic respiratory diseases like asthma and COPD, as well as for non-respiratory conditions.
Ready for Specialized Support Right Now?
At Phillips Medisize, a Molex company, our industry-optimized engineering and manufacturing approaches can help you enhance production efficiency, reduce risk and speed time to market.
For customized insights on your project, schedule a free consultation with one of our experts.